Previous 10 | Next 10 |
2024-05-01 11:54:02 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Amarin Corp (NASDAQ: AMRN ) just reported results for the first quarter of 2024. Amarin Corp reported earnings per share of -1 cent. This was above the analyst estimate fo...
2024-05-01 11:00:14 ET Image source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q1 2024 Earnings Call May 01, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript
2024-05-01 10:43:08 ET Amarin Corporation plc (AMRN) Q1 2024 Earnings Conference Call May 01, 2024 8:00 AM ET Company Participants Mark Marmur – Vice President, Corporate Communications and Investor Relations Patrick Holt – President and Chief Executive...
2024-05-01 07:04:37 ET More on Amarin Amarin Corporation: Small Signs Of Recovery May Not Be Enough Amarin Corporation plc (AMRN) Q4 2023 Earnings Call Transcript Amarin Q1 2024 Earnings Preview Amarin Non-GAAP EPS of $0.00 beats by $0.03, revenue of $74.71M ...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
2024-04-30 11:40:00 ET More on Amarin Amarin Corporation: Small Signs Of Recovery May Not Be Enough Amarin Corporation plc (AMRN) Q4 2023 Earnings Call Transcript Amarin Non-GAAP EPS of $0.00 beats by $0.03, revenue of $74.71M beats by $3.61M Seeking Alpha...
DUBLIN, Ireland and BRIDGEWATER, N.J., April 24, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced its support for a petition filed with the U.S. Food and Drug Administration (FDA) requesting that the Commissioner focus on and take further action to address significant...
DUBLIN, Ireland and BRIDGEWATER, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced shareholder approval of all proposed resolutions specified at its 2024 Annual General Meeting (AGM). Importantly, shareholders approved each of the two proposals required...
2024-04-16 13:51:41 ET Summary Amarin is going through a turbulent period with a strong contraction in revenue and margins. The EU and China markets seem too small to make significant changes, and the US market is suffering from margin erosion. The number of hedge funds that a...
DUBLIN, Ireland and BRIDGEWATER, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Patrick Holt, President & CEO, and members of Amarin’s senior management team to discuss its first quarter 2024 result...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...